Dr. Malmstrøm demonstrates how correlations between NMR data and bioactivity can be used to confirm the structure and activity of proteins.
Archive for: Bruker
An expert in pharmaceutical sciences discusses solid-state NMR spectroscopy as an advanced analytical technique to provide unique insight into the composition and properties of pharmaceutical formulations.
Renowned MRI expert, Prof. Jim Wild, will discuss the clinical applications of 129Xe lung imaging with a focus on novel pulmonary therapies using hyperpolarized gas and proton lung MRI as markers.
Experts discuss the synergies and implementation of state-of-the-art hybrid PET/MR technology and the new avenues of exploration it affords in the fields of neuroscience, cancer, and metabolic disease through to dual molecular probe development.
An infectious lung disease expert shares compelling evidence for the use of micro-CT to repeatedly evaluate disease progression and therapy efficacy in live animals.
An expert from AstraZeneca will discuss the use of antibody drugs, how they function and the different techniques used to characterize them in the drug development process.
Dr. Redente discusses the advantages of microCT and provides a broad overview of pulmonary disease imaging using a highly innovate technique to analyze living animals, as well as fixed tissue.
Experts provide a guided tour to PET image reconstruction for the application-oriented user. They share the pros and cons, and give you a glimpse of what to expect in the future with exciting insights into future trends.
Scientists discuss the use of NMR to analyze the antiviral drug Azidothymidine AZT, a medication currently used to prevent and treat HIV/AIDS.
Dr. Rohan Virgincar gives insight into the fundamentals of hyperpolarized 129Xe MRI and shares practical considerations for high-resolution imaging in rodent models of lung disease.